Jong Joseph Kim - Chief Executive Officer, Director at INOVIO PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
INO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jong Joseph Kim since 12 Mar 2025

Holdings reported by Jong Joseph Kim for INOVIO PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Unit 139,386 $1,137,390 $8.16 11 Mar 2022 Direct Common Stock
Common Stock 1,422,627 $796,671 $0.5600 11 Mar 2022 Direct
Common Stock 816,527 $457,255 $0.5600 11 Mar 2022 By Family Limited Partnership
Common Stock 33,775 $18,914 $0.5600 11 Mar 2022 By Son: JK1
Common Stock 33,563 $18,795 $0.5600 11 Mar 2022 By Daughter: EK
Common Stock 33,533 $18,778 $0.5600 11 Mar 2022 By Son: JK2
Common Stock 5,975 $3,346 $0.5600 11 Mar 2022 By Spouse
Common Stock Option 627,700 26 Feb 2022 Direct Common Stock

Transactions reported by Jong Joseph Kim for INOVIO PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.